Avinger(AVGR) - 2024 Q1 - Quarterly Results

Exhibit 99.1 Avinger Reports First Quarter 2024 Results Advances New OCT-Guided Coronary Product Development Redwood City, Calif., May 15, 2024 - Avinger, Inc. (Nasdaq: AVGR), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today reported results for the first quarter ended March 31, 2024. First Quarter and Recent Highlights ● Reported first quarter 2024 revenue of $1.9 m ...